← Back to Search

Behavioural Intervention

Cognitive Training for Cognitive Impairment

Phase 1

Recruiting

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, week 7, and 3-month

Awards & highlights

Study Summary

This trial will test a personalized computer-based cognitive program to see if it helps improve performance. The program adjusts difficulty to a person's biofeedback and cognitive performance. Participants will be randomized into two groups.

Who is the study for?

This trial is for people over 60 with mild cognitive impairment, who can read and understand English, have adequate vision and hearing, and are living independently. They should not be severely depressed or have major neurological conditions like Alzheimer's or Parkinson's. Participants must not be in another cognitive study or have serious heart issues.Check my eligibility

What is being tested?

The study tests a personalized computer-based cognitive training program that adjusts task difficulty based on the participant's biofeedback (heart rate) and performance. Participants will be randomly assigned to one of two game versions while their ECG is monitored to keep the group they're in secret.See study design

What are the potential side effects?

Since this intervention involves non-invasive computer-based tasks tailored using biofeedback, significant side effects are not anticipated. However, participants may experience fatigue or frustration during the cognitive tasks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, week 7, and 3-month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, week 7, and 3-month

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 7, and 3-month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

composite cognitive measure

Secondary outcome measures

central autonomic network (CAN) functional integrity

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: pSOPTExperimental Treatment1 Intervention

personalized cognitive training with a close-loop parasympathetic nervous system monitored component

Group II: MLAPlacebo Group1 Intervention

computerized mental leisure activities

Do I qualify?Apply below to find out

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,395 Previous Clinical Trials

17,341,300 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent are patients at risk with pSOPT treatments?

"There is limited clinical data to support the safety and efficacy of pSOPT, so it received a score of 1."

Answered by AI

Are there any vacancies in this experiment for participants?

"According to information on clinicaltrials.gov, this clinical trial is actively recruiting participants since its inception on October 12th 2023 and was recently updated on the 17th of same month."

Answered by AI

How many participants have enlisted in this research project?

"Affirmative. According to the information available on clinicaltrials.gov, this medical experiment is actively recruiting individuals--which was first posted on December 10th 2023 and recently edited October 17th 2023. The researchers are hoping to recruit 50 people from a single medical site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

CogT pSOPT Intervention Study

Feng Lin 2023. "CogT pSOPT Intervention Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06005038.